The store will not work correctly when cookies are disabled.
(2R,3S)-3-(3-hydroxypropyl)malate
ID: ALA387483
PubChem CID: 44423272
Max Phase: Preclinical
Molecular Formula: C7H12O6
Molecular Weight: 192.17
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)[C@@H](CCCO)[C@@H](O)C(=O)O
Standard InChI: InChI=1S/C7H12O6/c8-3-1-2-4(6(10)11)5(9)7(12)13/h4-5,8-9H,1-3H2,(H,10,11)(H,12,13)/t4-,5+/m0/s1
Standard InChI Key: KECVEWRVUJTIHH-CRCLSJGQSA-N
Molfile:
RDKit 2D
13 12 0 0 1 0 0 0 0 0999 V2000
-3.0750 -9.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3605 -9.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6461 -9.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9316 -9.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2138 -9.7618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9283 -8.5243 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6456 -10.5915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3599 -11.0044 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9309 -11.0037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9281 -11.8306 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2142 -10.5927 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.7895 -9.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5039 -9.7625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3 7 1 0
3 4 1 0
7 8 1 0
7 9 1 6
3 2 1 6
4 5 1 0
9 10 1 0
9 11 2 0
4 6 2 0
1 12 1 0
1 2 1 0
12 13 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 192.17 | Molecular Weight (Monoisotopic): 192.0634 | AlogP: -1.09 | #Rotatable Bonds: 6 |
Polar Surface Area: 115.06 | Molecular Species: ACID | HBA: 4 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.52 | CX Basic pKa: ┄ | CX LogP: -1.12 | CX LogD: -6.53 |
Aromatic Rings: ┄ | Heavy Atoms: 13 | QED Weighted: 0.42 | Np Likeness Score: 1.61 |
References
1. Yamamoto T, Miyazaki K, Eguchi T.. (2007) Substrate specificity analysis and inhibitor design of homoisocitrate dehydrogenase., 15 (3): [PMID:17116397] [10.1016/j.bmc.2006.11.008] |